Funding Raises Questions Of FDA's Authority

02/19/2002 | Seattle Times, The

Funding from the drug industry has paid for quick reviews and more approvals by the FDA. Current law, which limits access to taxpayer dollars, is set to expire in September and would leave the agency without primary funding to carry out drug approval and long-term safety monitoring.

View Full Article in:

Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI